SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-19-006005
Filing Date
2019-04-26
Accepted
2019-04-26 16:36:08
Documents
9
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 defa14a.htm DEFA14A 35817
2 image_001.jpg GRAPHIC 88421
3 image_002.jpg GRAPHIC 130464
4 image_003.jpg GRAPHIC 27334
5 image_004.jpg GRAPHIC 12089
6 image_005.jpg GRAPHIC 91411
7 image_006.jpg GRAPHIC 107913
8 image_007.jpg GRAPHIC 24169
9 image_008.jpg GRAPHIC 13447
  Complete submission text file 0001493152-19-006005.txt   719660
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38738 | Film No.: 19772224
SIC: 2834 Pharmaceutical Preparations